New York State Teachers Retirement System Sells 500 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

New York State Teachers Retirement System decreased its holdings in Phibro Animal Health Co. (NASDAQ:PAHC) by 9.7% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,653 shares of the company’s stock after selling 500 shares during the quarter. New York State Teachers Retirement System’s holdings in Phibro Animal Health were worth $105,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. BNP Paribas Financial Markets lifted its position in shares of Phibro Animal Health by 13.5% during the 1st quarter. BNP Paribas Financial Markets now owns 83,179 shares of the company’s stock valued at $1,076,000 after acquiring an additional 9,892 shares during the period. Illinois Municipal Retirement Fund lifted its position in Phibro Animal Health by 7.2% during the first quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock worth $148,000 after purchasing an additional 765 shares during the period. Acadian Asset Management LLC lifted its position in Phibro Animal Health by 32.8% during the first quarter. Acadian Asset Management LLC now owns 675,207 shares of the company’s stock worth $8,726,000 after purchasing an additional 166,776 shares during the period. Price T Rowe Associates Inc. MD grew its stake in Phibro Animal Health by 7.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock worth $200,000 after buying an additional 1,063 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its holdings in Phibro Animal Health by 56.0% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 79,667 shares of the company’s stock valued at $1,030,000 after buying an additional 28,584 shares during the period. Institutional investors own 99.34% of the company’s stock.

Insider Transactions at Phibro Animal Health

In other Phibro Animal Health news, Director E Thomas Corcoran purchased 5,000 shares of the company’s stock in a transaction dated Wednesday, September 4th. The stock was purchased at an average price of $20.02 per share, with a total value of $100,100.00. Following the completion of the purchase, the director now owns 25,000 shares of the company’s stock, valued at approximately $500,500. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 50.07% of the company’s stock.

Phibro Animal Health Trading Up 1.5 %

PAHC opened at $23.85 on Monday. The company has a market cap of $965.93 million, a P/E ratio of 55.47, a PEG ratio of 0.58 and a beta of 0.51. The company has a current ratio of 3.23, a quick ratio of 1.64 and a debt-to-equity ratio of 1.81. The company’s 50 day moving average is $22.37 and its 200-day moving average is $19.38. Phibro Animal Health Co. has a 1-year low of $9.40 and a 1-year high of $25.11.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.34 by $0.07. The business had revenue of $273.16 million during the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. Equities research analysts predict that Phibro Animal Health Co. will post 1.63 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date of this dividend is Wednesday, November 27th. Phibro Animal Health’s payout ratio is 111.63%.

Wall Street Analyst Weigh In

PAHC has been the subject of a number of recent analyst reports. Bank of America upped their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a report on Friday, August 30th. JPMorgan Chase & Co. started coverage on Phibro Animal Health in a research note on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price for the company. Three investment analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $14.75.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.